Business Context and Reporting Period
Company: Utah Medical Products, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: October 23, 2025
Reporting Period: The filing references financial information for the three and nine months ended September 30, 2025, and includes forward-looking statements for 2025 and beyond.
Key Financial Metrics
The provided text is a cover sheet for the Form 8-K and does not contain specific numerical data. It states that financial information regarding revenue, profit, cash flow, margins, debt, and liquidity is attached as Exhibit 99.1 (a press release dated October 23, 2025). Consequently, no specific financial metrics can be extracted from this text alone.
Material Changes
The filing text does not detail specific material changes versus prior periods. It indicates that such information is contained within the referenced Exhibit 99.1.
Guidance, Outlook, and Risks
Outlook: The filing incorporates forward-looking statements relating to 2025 and beyond, which are detailed in the attached press release (Exhibit 99.1).
Risks and Contingencies: The text notes that the information furnished pursuant to Item 2.02 is not deemed "filed" under Section 18 of the Exchange Act and is not subject to the liabilities of that section. Specific risks or contingencies are not listed in this cover document.
Investor Verification Checklist
- Review Exhibit 99.1 (the press release dated October 23, 2025) for actual revenue, profit, and cash flow figures for the three and nine months ended September 30, 2025.
- Verify the specific forward-looking statements and guidance for 2025 and beyond contained in the attached exhibit.
- Confirm the company's current liquidity position and debt levels, as these are not disclosed in the cover sheet.
- Note that the financial data in this filing is furnished and not "filed" for liability purposes under Section 18 of the Exchange Act.